|
|
|
|
pmid:28259984
|
|
|
|
|
pmid:28257738
|
|
|
|
|
pmid:28253591
|
Shetelig C et al. |
Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. |
2017 |
PLoS ONE |
pmid:28253327
|
|
|
|
|
pmid:28252575
|
|
|
|
|
pmid:28249772
|
Lu LY et al. |
Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway. |
2017 |
J. Orthop. Res. |
pmid:28248001
|
Irtyuga O et al. |
NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. |
2017 |
Biomed Res Int |
pmid:28246602
|
|
|
|
|
pmid:28244588
|
|
|
|
|
pmid:28244247
|
Hanmoto T et al. |
Effects of low-intensity pulsed ultrasound on osteoclasts: Analysis with goldfish scales as a model of bone. |
2017 |
Biomed. Res. |
pmid:28239034
|
Fioramonti M et al. |
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. |
2017 |
Oncotarget |
pmid:28223547
|
|
|
|
|
pmid:28214531
|
Xiong L et al. |
Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. |
2017 |
J. Cell Biol. |
pmid:28193701
|
|
|
|
|
pmid:28189120
|
Fortner RT et al. |
Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort. |
2017 |
BMC Med |
pmid:28173834
|
|
|
|
|
pmid:28165889
|
Kuroyanagi G et al. |
(-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. |
2017 |
Prostaglandins Other Lipid Mediat. |
pmid:28163121
|
|
|
|
|
pmid:28161839
|
|
|
|
|
pmid:28153008
|
Chung ST et al. |
Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells. |
2017 |
Mol. Cancer |
pmid:28143606
|
|
|
|
|
pmid:28130552
|
|
|
|
|
pmid:28127738
|
|
|
|
|
pmid:28126632
|
Yin LL et al. |
Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients. |
2017 |
Eur Rev Med Pharmacol Sci |
pmid:28121359
|
|
|
|
|
pmid:28115012
|
Bondar C et al. |
Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease. |
2017 |
Int J Mol Sci |
pmid:28098793
|
Liu XY et al. |
Protective effects of total flavonoids of Astragalus against adjuvant-induced arthritis in rats by regulating OPG/RANKL/NF-κB pathway. |
2017 |
Int. Immunopharmacol. |
pmid:28092862
|
|
|
|
|
pmid:28091892
|
Bergamini A et al. |
Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy. |
2016 |
Int J Med Sci |
pmid:28090190
|
|
|
|
|
pmid:28088671
|
Shu R et al. |
Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement. |
2017 |
PLoS ONE |
pmid:28081119
|
|
|
|
|
pmid:28079506
|
|
|
|
|
pmid:28077433
|
Toffoli B et al. |
Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System. |
2016 |
Mediators Inflamm. |
pmid:28070143
|
Ji J et al. |
Pathway of 3-MCPD-induced apoptosis in human embryonic kidney cells. |
2017 |
J Toxicol Sci |
pmid:28070108
|
Chen H et al. |
[Effects of laser solid forming of porous titanium on proliferation of osteoblast and RANKL/OPG expression]. |
2016 |
Zhong Nan Da Xue Xue Bao Yi Xue Ban |
pmid:28070039
|
Sponder M et al. |
Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study. |
2017 |
BMC Cardiovasc Disord |
pmid:28056805
|
Hygum K et al. |
MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. |
2017 |
Eur. J. Endocrinol. |
pmid:28049653
|
|
|
|
|
pmid:28044198
|
|
|
|
|
pmid:28041995
|
Shimazaki E et al. |
TGF-β and Physiological Root Resorption of Deciduous Teeth. |
2016 |
Int J Mol Sci |
pmid:28035998
|
|
|
|
|
pmid:28004300
|
|
|
|
|
pmid:28002811
|
|
|
|
|
pmid:28002265
|
Bolamperti S et al. |
Evidence for Altered Canonical Wnt Signaling in the Trabecular Bone of Elderly Postmenopausal Women with Fragility Femoral Fracture. |
2016 |
Biomed Res Int |
pmid:27999816
|
Li Y et al. |
Osteoprotegerin polymorphisms are associated with alcohol-induced osteonecrosis of femoral head in Chinese Han population from Henan province. |
2016 |
J. Genet. |
pmid:27994198
|
|
|
|
|
pmid:27983911
|
|
|
|
|
pmid:27976811
|
|
|
|
|
pmid:27956350
|
|
|
|
|
pmid:27930925
|
|
|
|
|
pmid:27927880
|
|
|
|
|
pmid:27925188
|
|
|
|
|
pmid:27922673
|
|
|
|
|
pmid:27918081
|
Gómez-Vaquero C et al. |
Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis. |
2016 |
PLoS ONE |
pmid:27911913
|
|
|
|
|
pmid:27905067
|
Zhang L et al. |
Role of Osteoprotegerin (OPG) in Bone Marrow Adipogenesis. |
2016 |
Cell. Physiol. Biochem. |
pmid:27898403
|
|
|
|
|
pmid:27893411
|
Biscetti F et al. |
RANK/RANKL/OPG pathway: genetic association with history of ischemic stroke in Italian population. |
2016 |
Eur Rev Med Pharmacol Sci |
pmid:27874938
|
Liu FQ et al. |
Effects of Salt Loading on Plasma Osteoprotegerin Levels and Protective Role of Potassium Supplement in Normotensive Subjects. |
2016 |
Circ. J. |
pmid:27867157
|
|
|
|
|
pmid:27862210
|
Kim CS et al. |
Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. |
2016 |
PLoS ONE |
pmid:27855207
|
|
|
|
|
pmid:27849387
|
|
|
|
|
pmid:27845067
|
Li XJ et al. |
Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice. |
2016 |
Int. J. Mol. Med. |
pmid:27840967
|
Zhou J and Zhao Y |
Osteoprotegerin Gene (OPG) Polymorphisms Associated with Peri-implantitis Susceptibility in a Chinese Han Population. |
2016 |
Med. Sci. Monit. |
pmid:27828936
|
Ostrowska Z et al. |
TGF-β1, bone metabolism, osteoprotegerin, and soluble receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa. |
2016 |
Endokrynol Pol |
pmid:27828689
|
|
|
|
|
pmid:27826889
|
|
|
|
|
pmid:27809640
|
|
|
|
|
pmid:27796050
|
|
|
|
|
pmid:27783536
|
|
|
|
|
pmid:27783278
|
|
|
|
|
pmid:27783097
|
Kan C et al. |
Cancer Cell Colonisation in the Bone Microenvironment. |
2016 |
Int J Mol Sci |
pmid:27782035
|
Huang HM et al. |
Effects of Roughly Focused Extracorporeal Shock Waves Therapy on the Expressions of Bone Morphogenetic Protein-2 and Osteoprotegerin in Osteoporotic Fracture in Rats. |
2016 |
Chin. Med. J. |
pmid:27779163
|
|
|
|
|
pmid:27772699
|
|
|
|
|
pmid:27771584
|
|
|
|
|
pmid:27766484
|
|
|
|
|
pmid:27764814
|
Kamata R et al. |
EPA Prevents the Development of Abdominal Aortic Aneurysms through Gpr-120/Ffar-4. |
2016 |
PLoS ONE |
pmid:27764222
|
Liu HJ et al. |
Substance P Promotes the Proliferation, but Inhibits Differentiation and Mineralization of Osteoblasts from Rats with Spinal Cord Injury via RANKL/OPG System. |
2016 |
PLoS ONE |
pmid:27764190
|
|
|
|
|
pmid:27760011
|
|
|
|
|
pmid:27743302
|
O'Sullivan S et al. |
Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. |
2016 |
PLoS ONE |
pmid:27737004
|
|
|
|
|
pmid:27736364
|
|
|
|
|
pmid:27730697
|
|
|
|
|
pmid:27729453
|
|
|
|
|
pmid:27720655
|
|
|
|
|
pmid:27711964
|
|
|
|
|
pmid:27710831
|
|
|
|
|
pmid:27710796
|
Li M et al. |
Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis. |
2016 |
J. Biol. Chem. |
pmid:27697839
|
|
|
|
|
pmid:27692945
|
|
|
|
|
pmid:27684563
|
|
|
|
|
pmid:27665233
|
|
|
|
|
pmid:27664484
|
|
|
|
|
pmid:27663616
|
|
|
|
|
pmid:27651300
|
|
|
|
|
pmid:27650950
|